SWAV 0.00 Stock Price ShockWave Medical, Inc.
Range: | 157.0-334.9 | Vol Avg: | 1246461 | Last Div: | 0 | Changes: | -0.08 |
Beta: | 0.88 | Cap: | 12.57B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Thu Mar 07 2019 | Empoloyees: | 1468 |
CUSIP: | 82489T104 | CIK: | 0001642545 | ISIN: | US82489T1043 | Country: | US |
CEO: | Mr. Douglas E. Godshall M.B.A. | Website: | https://www.shockwavemedical.com |
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.